NF2 and cancer: Fifteen of the NF2 missense variants included in this study were observed exclusively in somatic samples from non‐NF2 related tumors, and this is consistent with previous observations of somatic NF2 variants in multiple cancer types, such as mesothelioma, liver, and large instestine cancers (Schroeder et al., 2014).